Related references
Note: Only part of the references are listed.HER2, TOP2A, CCND1, EGFR and c-MYC oncogene amplification in colorectal cancer
Khawla Al-Kuraya et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
Intron 1 CA dinucleotide repeat polymorphism and mutations of epidermal growth factor receptor and gefitinib responsiveness in non-small-cell lung cancer
Sae-Won Han et al.
PHARMACOGENETICS AND GENOMICS (2007)
Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFOX-4 chemotherapy
Annamaria Ruzzo et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Antibody-dependent cellular cytotoxicity mediated by cetuximab against lung cancer cell lines
Jun Kurai et al.
CLINICAL CANCER RESEARCH (2007)
Targeted therapy in colorectal cancer
Scott Wadler
CLINICAL COLORECTAL CANCER (2007)
Mechanisms of egfr gene transcription modulation:: Relationship to cancer risk and therapy response
Burkhard Brandt et al.
CLINICAL CANCER RESEARCH (2006)
Transcriptional profiling identifies cyclin D1 as a critical downstream effector of mutant epidermal growth factor receptor signaling
Susumu Kobayashi et al.
CANCER RESEARCH (2006)
Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: Implications for cancer therapy
Elizabeth S. Henson et al.
CELLULAR SIGNALLING (2006)
Epigenetic inactivation of EGFR by CpG island hypermethylation in cancer
Alberto J. Montero et al.
CANCER BIOLOGY & THERAPY (2006)
Irinotecan in the treatment of colorectal cancer
Charles Fuchs et al.
CANCER TREATMENT REVIEWS (2006)
Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines
Heinz-Josef Lenz et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Mitogenic and apoptotic actions of epidermal growth factor on neuroblastoma cells are concentration-dependent
Bill Chiu et al.
JOURNAL OF SURGICAL RESEARCH (2006)
Epidermal growth factor (EGF) induces apoptosis in a transfected cell line expressing EGF receptor on its membrane
Xiaorong Zhao et al.
CELL BIOLOGY INTERNATIONAL (2006)
Epidermal growth factor receptor targeting in cancer
John Mendelsohn et al.
SEMINARS IN ONCOLOGY (2006)
Cyclin D1 and epidermal growth factor polymorphisms associated with survival in patients with advanced colorectal cancer treated with Cetuximab
Wu Zhang et al.
PHARMACOGENETICS AND GENOMICS (2006)
EGF-ERBB signalling: towards the systems level
Ami Citri et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
EGFR in colorectal cancer:: more than a simple receptor
M. Francoual et al.
ANNALS OF ONCOLOGY (2006)
Epidermal growth factor receptor dimerization status determines skin toxicity to HER-kinase targeted therapies
I Laux et al.
BRITISH JOURNAL OF CANCER (2006)
Correlation between the response to cetuximab alone or in combination with irinotecan and the activated/phosphorylated epidermal growth factor receptor in metastatic colorectal cancer
N Personeni et al.
SEMINARS IN ONCOLOGY (2005)
Role of antibody-dependent cell-mediated cytotoxicity in the efficacy of therapeutic anti-cancer monoclonal antibodies
A Iannello et al.
CANCER AND METASTASIS REVIEWS (2005)
Epidermal growth factor receptor expression and gene amplification in colorectal carcinoma:: an immunohistochemical and chromogenic in situ hybridization study
J Shia et al.
MODERN PATHOLOGY (2005)
Functional promoter SNPs in cell cycle checkpoint genes
H Bélanger et al.
HUMAN MOLECULAR GENETICS (2005)
Pharmacokinetic profile of cetuximab (Erbitux™) alone and in combination with irinotecan in patients with advanced EGFR-positive adenocarcinoma
C Delbaldo et al.
EUROPEAN JOURNAL OF CANCER (2005)
Analysis of the dinucleotide repeat polymorphism in the epidermal growth factor receptor (EGFR) gene in head and neck cancer patients
MC Etienne-Grimaldi et al.
ANNALS OF ONCOLOGY (2005)
SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci
YY Shi et al.
CELL RESEARCH (2005)
Monoclonal antibody therapy of cancer
GP Adams et al.
NATURE BIOTECHNOLOGY (2005)
Ligand-induced, p38-dependent apoptosis in cells expressing high levels of epidermal growth factor receptor and ErbB-2
O Tikhomirov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Enhancement of the antibody-dependent cellular cytotoxicity of low-fucose IgG1 is independent of FcγRIIIa functional polymorphism
R Niwa et al.
CLINICAL CANCER RESEARCH (2004)
Haplotype reconstruction from genotype data using Imperfect Phylogeny
E Halperin et al.
BIOINFORMATICS (2004)
An epidermal growth factor receptor intron 1 polymorphism mediates response to epidermal growth factor receptor inhibitors
ML Amador et al.
CANCER RESEARCH (2004)
Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer
D Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Immunohistochemical detection of EGFR in paraffin-embedded tumor tissues:: Variation in staining intensity due to choice of fixative and storage time of tissue sections
D Atkins et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2004)
Flow cytometric determination of FcγRIIa (CD32) polymorphism
A van Royen-Kerkhof et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2004)
Allelic length of a CA dinucleotide repeat in the egfr gene correlates with the frequency of amplifications of this sequence -: first results of an inter-ethnic breast cancer study
H Buerger et al.
JOURNAL OF PATHOLOGY (2004)
Evaluation of the epidermal growth factor receptor (EGFR) in colorectal tumours and lymph node metastases
JA McKay et al.
EUROPEAN JOURNAL OF CANCER (2002)
Epidermal growth factor inhibits the growth of TE8 esophageal cancer cells through the activation of STAT1
M Ichiba et al.
JOURNAL OF GASTROENTEROLOGY (2002)
Quantification of the completeness of follow-up
TG Clark et al.
LANCET (2002)
Association between functional polymorphism in EGF gene and malignant melanoma
M Shahbazi et al.
LANCET (2002)
Differential sensitivity of cancer cells to inhibitors of the epidermal growth factor receptor family
PC Bishop et al.
ONCOGENE (2002)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
